@article{c281311c4e3d4607a136251a33b15f53,
title = "Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab",
abstract = "N/a",
keywords = "Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Disease-Free Survival, Female, Humans, Leukemia, Lymphocytic, Chronic, B-Cell, Male, Middle Aged, Purines, Quinazolinones, Rituximab, Survival Rate, Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Disease-Free Survival, Female, Humans, Leukemia, Lymphocytic, Chronic, B-Cell, Male, Middle Aged, Purines, Quinazolinones, Rituximab, Survival Rate",
author = "Luca Laurenti and Marino Gentile and Rossi, {Federica Maria} and Robin Foa and Francesco Morabito and Massimo Gentile and Martino, {Enrica Antonia} and Andrea Visentin and Marta Coscia and Gianluigi Reda and Paolo Sportoletti and Mauro, {Francesca Romana} and Marzia Varettoni and Roberta Murru and Annalisa Chiarenza and Ernesto Vigna and Francesco Mendicino and Eugenio Lucia and Sabrina Bossio and Recchia, {Anna Grazia} and Riccardo Moia and Daniela Pietrasanta and Giacomo Loseto and Ugo Consoli and Ilaria Scortechini and Rossi, {Francesca Maria} and Antonella Zucchetto and Hamdi Al-Janazreh and Candida Vitale and Giovanni Tripepi and Graziella D{\textquoteright}Arrigo and Ilaria Angeletti and Riccardo Bomben and Antonino Neri and Giovanna Cutrona and Gilberto Fronza and {Di Raimondo}, Francesco and Gianluca Gaidano and Antonio Cuneo and Robin Fo{\`a} and Manlio Ferrarini and Livio Trentin and Valter Gattei and Fortunato Morabito",
year = "2020",
doi = "10.1038/s41408-020-00358-3",
language = "English",
volume = "10",
pages = "92--N/A",
journal = "Blood Cancer Journal",
issn = "2044-5385",
publisher = "Nature Publishing Group (NPG)",
}